Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to evaluate the effects of a personalized vision therapy programme tailored to baseline visual-cognitive abilities in treatment-resistant amblyopia. In addition ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Okan University
NCT03655912 · Amblyopia
NCT07417046 · Amblyopia, VEP
NCT06928727 · Craniosynostosis, Strabismus, and more
NCT06380517 · Amblyopia
NCT04378790 · Amblyopia
Okan University
Istanbul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions